Dr. Steve Groff, a board-certified physician and the owner of the first HempTrain in the US, is thrilled about his Alma Mater’s new research findings.
Penn State Hershey Medical Center has released a new study suggesting that cannabinoids may inhibit colon cancer cell growth. This research also suggests that THC nor CBD slowed cancer cell growth, further implying that Hemp, a cannabis plant with under .3% THC by dry weight, may hold anti-neoplastic properties. This study specifically suggests that other molecules found in cannabis may hold the most promise for these patients.
In preparation for Groff North America’s Hemp Farmers Supper, Groff stated: “This work from Hershey Med is so exciting and timely as we gather a number of interested farmers from PA to help build an industry from an old plant!”
Click Here to view the original article from CGT.